Intraventricular electrogram mapping and radiofrequency cardiac ablation for ventricular tachycardia.
Since its first use in the early 1980s, radiofrequency catheter ablation has gained acceptance as primary therapy for many cardiac rhythm disorders. This article reviews fundamentals of cardiac mapping and radiofrequency ablation and their clinical use for treatment of ventricular tachycardia. The review concludes that the use of radiofrequency ablation to cure ventricular tachycardia has consistently increased over the years, as better mapping and ablation tools have been made available to the medical community. Presently, high success and low complication rates are achieved only in patients with bundle branch, idiopathic, or monomorphic and stable ventricular tachycardias. The reviewed studies and reports suggest that, in order to increase the success rates in patients with ventricular tachycardias caused by coronary artery disease, mapping systems that can identify arrhythmogenic pathways more accurately and more efficiently and ablation devices capable of generating larger lesions are needed.
Panescu
D
D
EP Technologies, Boston Scientific Company, Sunnyvale, CA 94086, USA.
D017115:Catheter Ablation / Q000295:instrumentation / Q000379:methods; D003326:Coronary Circulation; D004562:Electrocardiography; D004867:Equipment Design; D006801:Humans; D017180:Tachycardia, Ventricular / Q000175:diagnosis* / Q000503:physiopathology / Q000601:surgery*; D013696:Temperature; D013997:Time Factors